The Burden of Cognitive Dysfunction in Multiple Sclerosis
Christopher Lock, MD
Strategies to Safeguard Brain Health in MS
Switching to Risdiplam Maintains Motor Gains in SMA Patients
Ryan Quigley
Who’s Missing from Multiple Sclerosis Research?
Ashley Baker, MSN, PMHNP
Ruth Ann Marrie, MD, PhD
GFAP and VEGF Trajectories in Adult Type 3 Spinal Muscular Atrophy Under Nusinersen
CK1δ Inhibition and Riluzole in ALS: Synergy at Lower Doses
Multiple Sclerosis Without Borders: Taking a Global View
Andrew Wilner, MD, FACP, FAAN
Victor Rivera, MD
Understanding Accelerated Biological Aging in Pediatric MS
Jennifer Yang, MD
Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
Raphael Schneider, MD, PhD, FRCPC, CIP
Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers
Adil Harroud, MD
Dylan Hamitouche
Beyond the Primary Endpoint: What OCEANIC-STROKE Subtype Analyses Reveal About Asundexian’s Potential
Ashkan Shoamanesh, MD
OCEANIC-STROKE Results: Asundexian for Secondary Stroke Prevention After Acute Non-Cardioembolic Stroke or High-Risk TIA
Mike Sharma, MD, MSc, FRCPC
Delivering a Hopeful, Recovery-Oriented Schizophrenia Diagnosis
Alexandria May, PharmD, BCPS
Apurva Bhatt, MD
Iron Deposition and Cognitive Fatigue in Multiple Sclerosis
Evaluating Structured Interventions for Cognitive Support in MS
Hallie Blevins, PhD
Optimizing Vitamin D Supplementation in MS Care
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.